We are exactly five years away from our target exit date and our leadership team is divided on whether we should keep aggressively reinvesting our profits back into R&D and acquisitions or start pulling back to maximize our distributions. How do we resolve this strategic tension on our V/TO® so we do not kill our long-term valuation?

Question

Tyler Smith · Accepted Answer

At the five year mark, this tension must be resolved directly on your V/TO® to prevent your leadership team from pulling in opposite directions. Buyers look for a clean, historical track record of consistent growth, which requires smart capital allocation. If you choke off R&D and acquisitions too early just to maximize short-term distributions, you will present a decaying asset to the market, which severely depresses your multiple.

To resolve this, you need to use your annual planning session to define your ideal buyer profile and work backward. If your target buyers are strategic acquirers, they will pay a premium for market share and proprietary capabilities, meaning you should keep investing in R&D. If your target buyers are private equity firms, they will prioritize predictable cash flow and EBITDA, meaning you should focus on operational efficiency and optimization.

Use your V/TO® to document a clear strategic compromise. Set a specific threshold where a portion of your profits is strictly allocated to fuel sustainable growth, while the remainder is distributed to shareholders. This ensures you maintain a healthy trajectory that appeals to high-value buyers while systematically rewarding the ownership team for their years of hard work. By making this choice explicit, your leadership team can align their quarterly Rocks with a unified financial strategy.